{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T20:15:47Z","timestamp":1723061747947},"reference-count":33,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2018]]},"DOI":"10.3960\/jslrt.17031","type":"journal-article","created":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T22:15:57Z","timestamp":1518041757000},"page":"10-16","source":"Crossref","is-referenced-by-count":1,"title":["Clinical management and outcomes of completely resected stage I follicular lymphoma"],"prefix":"10.3960","volume":"58","author":[{"given":"Akihiko","family":"Yokohama","sequence":"first","affiliation":[{"name":"Blood Transfusion Service, Gunma University Hospital, Faculty of Medicine, Gunma University, Maebashi, Gunma, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Hematology, Gunma University Graduate School of Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Takizawa","sequence":"additional","affiliation":[{"name":"Department of Hematology, Gunma University Graduate School of Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Gunma University Graduate School of Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Miyazawa","sequence":"additional","affiliation":[{"name":"Division of Hematology, National Hospital Organization Shibukawa Medical Center, Shibukawa, Gunma, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Saitoh","sequence":"additional","affiliation":[{"name":"Department of Hematology, Fujioka General Hospital, Fujioka, Gunma, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohtaro","family":"Toyama","sequence":"additional","affiliation":[{"name":"Department of Hematology, Fujioka General Hospital, Fujioka, Gunma, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuma","family":"Ishizaki","sequence":"additional","affiliation":[{"name":"Department of Hematology, Gunma University Graduate School of Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeki","family":"Mitsui","sequence":"additional","affiliation":[{"name":"Department of Hematology, Gunma University Graduate School of Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Saitoh","sequence":"additional","affiliation":[{"name":"Gunma University Graduate School of Health Sciences, Maebashi, Gunma, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayoko","family":"Murayama","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Gunma Cancer Center, Ohta, Gunma, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morio","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Division of Hematology, National Hospital Organization Shibukawa Medical Center, Shibukawa, Gunma, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morio","family":"Sawamura","sequence":"additional","affiliation":[{"name":"Division of Hematology, National Hospital Organization Shibukawa Medical Center, Shibukawa, Gunma, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Murakami","sequence":"additional","affiliation":[{"name":"Gunma University Graduate School of Health Sciences, Maebashi, Gunma, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Hirato","sequence":"additional","affiliation":[{"name":"Clinical Department of Pathology, Gunma University Hospital, Maebashi, Gunma, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Kojima","sequence":"additional","affiliation":[{"name":"Anatomic and Diagnostic Pathology, Dokkyo University School of Medicine, Mibu, Tochigi, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Nojima","sequence":"additional","affiliation":[{"name":"Department of Hematology, Gunma University Graduate School of Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Handa","sequence":"additional","affiliation":[{"name":"Department of Hematology, Gunma University Graduate School of Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norifumi","family":"Tsukamoto","sequence":"additional","affiliation":[{"name":"Oncology Center, Gunma University Hospital, Maebashi, Gunma, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Hiromi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Koiso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","unstructured":"1 Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin\u2019s lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin\u2019s Lymphoma Classification Project. J Clin Oncol. 1998; 16: 2780-2795."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Fisher SG, Fisher RI. The epidemiology of non-Hodgkin\u2019s lymphoma. Oncogene. 2004; 23: 6524-6534.","DOI":"10.1038\/sj.onc.1207843"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Takata K, Miyata-Takata T, Sato Y <i>et al.<\/i> Pathology of Follicular Lymphoma. J Clin Exp Hematop. 2014; 54: 3-9.","DOI":"10.3960\/jslrt.54.3"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Cheson BD, Fisher RI, Barrington SF <i>et al.<\/i> Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014; 32: 3059-3068.","DOI":"10.1200\/JCO.2013.54.8800"},{"key":"5","unstructured":"5 Zelenetz AD, Abramson JS, Advani RH <i>et al.<\/i> NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin\u2019s lymphomas. J Natl Compr Canc Netw. 2010; 8: 288-334."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Dreyling M, Ghielmini M, Rule S <i>et al.<\/i> Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016; 27: 83-90.","DOI":"10.1093\/annonc\/mdw400"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Pugh TJ, Ballonoff A, Newman F <i>et al.<\/i> Improved survival in patients with early stage low-grade follicular lymphoma treated with radiation: a Surveillance, Epidemiology, and End Results database analysis. Cancer. 2010; 116: 3843-3851.","DOI":"10.1002\/cncr.25149"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Shah BK, Ghimire KB. Survival in adult stage I follicular lymphoma treated with and without radiotherapy - a populationbased study. Acta Oncol. 2015; 54: 951-953.","DOI":"10.3109\/0284186X.2014.974829"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Friedberg JW, Byrtek M, Link BK <i>et al.<\/i> Effectiveness of first-line management strategies for stage I follicular lymphoma: analysis of the National LymphoCare Study. J Clin Oncol. 2012; 30: 3368-3375.","DOI":"10.1200\/JCO.2011.40.6546"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Michallet AS, Lebras LL, Bauwens DD <i>et al.<\/i> Early stage follicular lymphoma: what is the clinical impact of the first-line treatment strategy? J Hematol Oncol. 2013; 6: 45.","DOI":"10.1186\/1756-8722-6-45"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Janikova A, Bortlicek Z, Campr V <i>et al.<\/i> Radiotherapy with rituximab may be better than radiotherapy alone in first-line treatment of early-stage follicular lymphoma: is it time to change the standard strategy? Leuk Lymphoma. 2015; 56: 2350-2356.","DOI":"10.3109\/10428194.2014.990010"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Mac Manus MP, Hoppe RT. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University. J Clin Oncol. 1996; 14: 1282-1290.","DOI":"10.1200\/JCO.1996.14.4.1282"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Ahmed N, Owen TE, Rubinger M <i>et al.<\/i> Early stage W.H.O. grade I and II follicular lymphoma treated with radiation therapy alone. PLoS One. 2013; 8: e65156.","DOI":"10.1371\/journal.pone.0065156"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Seymour JF, Pro B, Fuller LM <i>et al.<\/i> Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin\u2019s lymphoma. J Clin Oncol. 2003; 21: 2115-2122.","DOI":"10.1200\/JCO.2003.07.111"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Advani R, Rosenberg SA, Horning SJ. Stage I and II follicular non-Hodgkin\u2019s lymphoma: long-term follow-up of no initial therapy. J Clin Oncol. 2004; 22: 1454-1459.","DOI":"10.1200\/JCO.2004.10.086"},{"key":"16","unstructured":"16 Harris N, Swerdlow S, Jaffe E, <i>et al.<\/i> Follicular lymphoma. 4th ed, Lyon, International Agency for Reseach on Cancer. 2008; pp. 220-226."},{"key":"17","unstructured":"17 Rosenberg SA. Validity of the Ann Arbor staging classification for the non-Hodgkin\u2019s lymphomas. Cancer Treat Rep. 1977; 61: 1023-1027."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Herfarth K, Schnaidt S. Early stage nodal follicular lymphoma using IF radiotherapy and Rituximab: results of the MIR trial of the GLSG and ARO. Radiother Oncol. 2014; 111: S204.","DOI":"10.1016\/S0167-8140(15)30624-1"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Vargo JA, Gill BS, Balasubramani GK <i>et al.<\/i> What is the optimal management of early-stage low-grade follicular lymphoma in the modern era? Cancer. 2015; 121: 3325-3334.","DOI":"10.1002\/cncr.29491"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Bista A, Sharma S, Shah BK. Disparities in Receipt of Radiotherapy and Survival by Age, Sex, and Ethnicity among Patient with Stage I Follicular Lymphoma. Front Oncol. 2016; 6: 101.","DOI":"10.3389\/fonc.2016.00101"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Soubeyran P, Eghbali H, Trojani M <i>et al.<\/i> Is there any place for a wait-and-see policy in stage I0 follicular lymphoma? A study of 43 consecutive patients in a single center. Ann Oncol. 1996; 7: 713-718.","DOI":"10.1093\/oxfordjournals.annonc.a010720"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Pendlebury S, el Awadi M, Ashley S <i>et al.<\/i> Radiotherapy results in early stage low grade nodal non-Hodgkin\u2019s lymphoma. Radiother Oncol. 1995; 36: 167-171.","DOI":"10.1016\/0167-8140(95)01600-L"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Wilder RB, Jones D, Tucker SL <i>et al.<\/i> Long-term results with radiotherapy for Stage I-II follicular lymphomas. Int J Radiat Oncol Biol Phys. 2001; 51: 1219-1227.","DOI":"10.1016\/S0360-3016(01)01747-3"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Guadagnolo BA, Li S, Neuberg D <i>et al.<\/i> Longterm outcome and mortality trends in early-stage, Grade 1-2 follicular lymphoma treated with radiation therapy. Int J Radiat Oncol Biol Phys. 2006; 64: 928-934.","DOI":"10.1016\/j.ijrobp.2005.08.010"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Hiddemann W, Cheson BD. How we manage follicular lymphoma. Leukemia. 2014; 28: 1388-1395.","DOI":"10.1038\/leu.2014.91"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Izutsu K. Treatment of follicular lymphoma. J Clin Exp Hematop. 2014; 54: 31-37.","DOI":"10.3960\/jslrt.54.31"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Jerusalem G, Beguin Y, Najjar F <i>et al.<\/i> Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of lowgrade non-Hodgkin\u2019s lymphoma (NHL). Ann Oncol. 2001; 12: 825-830.","DOI":"10.1023\/A:1011169332265"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Weiler-Sagie M, Bushelev O, Epelbaum R <i>et al.<\/i> (18)F-FDG avidity in lymphoma readdressed: a study of 766 patients. J Nucl Med. 2010; 51: 25-30.","DOI":"10.2967\/jnumed.109.067892"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Wirth A, Foo M, Seymour JF <i>et al.<\/i> Impact of [18F] fluorodeoxyglucose positron emission tomography on staging and management of early-stage follicular non-hodgkin lymphoma. Int J Radiat Oncol Biol Phys. 2008; 71: 213-219.","DOI":"10.1016\/j.ijrobp.2007.09.051"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Metser U, Dudebout J, Baetz T <i>et al.<\/i> [18F]-FDG PET\/CT in the staging and management of indolent lymphoma: A prospective multicenter PET registry 7 Resected follicular lymphoma study. Cancer. 2017; 123: 2860-2866.","DOI":"10.1002\/cncr.30672"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Sancho JM, Garcia O, Mercadal S <i>et al.<\/i> The long term follow-up of early stage follicular lymphoma treated with radiotherapy, chemotherapy or combined modality treatment. Leuk Res. 2015; 39: 853-858.","DOI":"10.1016\/j.leukres.2015.05.009"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Cencini E, Fabbri A, Schiattone L <i>et al.<\/i> Radiotherapy with rituximab as first-line treatment for earlystage follicular lymphoma. Leuk Lymphoma. 2015; 56: 2997-2998.","DOI":"10.3109\/10428194.2015.1022768"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Ruella M, Filippi AR, Bruna R <i>et al.<\/i> Addition of Rituximab to Involved-Field Radiation Therapy Prolongs Progression-free Survival in Stage I-II Follicular Lymphoma: Results of a Multicenter Study. Int J Radiat Oncol Biol Phys. 2016; 94: 783-791.","DOI":"10.1016\/j.ijrobp.2015.12.019"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/58\/1\/58_17031\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T14:26:43Z","timestamp":1570717603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/58\/1\/58_17031\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.17031","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"type":"print","value":"1346-4280"},{"type":"electronic","value":"1880-9952"}],"subject":[],"published":{"date-parts":[[2018]]}}}